(Q38072262)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23296110%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

review article

1 reference

title

Brain cancer in 2012: Molecular characterization leads the way (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23296110%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23296110%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

author name string

Roger Stupp

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23296110%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

language of work or name

English

0 references

publication date

8 January 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23296110%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Clinical Oncology

21 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23296110%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23296110%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23296110%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

page(s)

69-70

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23296110%20AND%20SRC:MED&resulttype=core&format=json

Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial

21 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.240

Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.240

Randomized trial of radiation therapy plus procarbazine, lomustine, and vincristine chemotherapy for supratentorial adult low-grade glioma: initial results of RTOG 9802.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.240

NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.240

2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated patients with gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.240

The clinical implications of medulloblastoma subgroups

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.240

Novel mutations target distinct subgroups of medulloblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.240

Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.240

10.1038/NRCLINONC.2012.240

31 March 2020

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23296110%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

1 reference